Longitudinal Analysis of Drug Burden Index

January 13, 2017 updated by: Katja Taxis, University of Groningen

Longitudinal Analysis of Cumulative Exposure to Anticholinergic and Sedative Drugs Measured With the Drug Burden Index

Anticholinergic and sedative drugs are frequently prescribed to older people, despite their negative impact on older people's physical and cognitive function. To estimate the cumulative exposure to anticholinergic and sedative drugs, Hilmer et al. published the Drug Burden Index (DBI) in 2007. The present study aims to complement previous study findings showing higher DBI values to be associated with physical and cognitive impairment. Most previously conducted studies of the DBI were either cross-sectional or were longitudinal but with short follow-ups. Furthermore, it remains unknown whether higher DBI values carry extra risks for patients with dementia. Finally, relatively little is known about the stability of DBI values over time. The current project therefore aims to examine (1) longitudinal relationships between long-term cumulative exposure to anticholinergic and sedative drugs as measured with the DBI and cognitive and physical function, (2) to examine interaction effects between DBI exposure and dementia, and (3) to examine trajectories of DBI exposure, i.e. DBI exposure remaining stable, declining, increasing or fluctuating over time. These project aims will be studied with longitudinal data from eligible participants > 60 years from the LASA study with participants being followed-up during two decades, and the longitudinal data from the InterRAI consortium. Various clinical outcomes regarding cognitive and physical function will be studied. Data will be analysed with generalised linear mixed models and Latent Class Growth Analysis.

Study Overview

Study Type

Observational

Enrollment (Actual)

9985

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

55 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

People aged 55 years and older, both community-dwelling individuals and individuals living in residential aged care facilities

Description

LASA:

Inclusion criteria:

  • 55 years and older

Exclusion criteria:

  • problem drinkers in the past and the present
  • very severe vision and hearing problems

InterRAI:

Inclusion criteria:

  • 55 years or older

Exclusion criteria:

  • consumption of 5 or more units of alcohol on one occasion
  • unknown sex or age

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
LASA study
InterRAI consortium

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
LASA study: Alphabet Coding Task
Time Frame: 21 years: 7 waves separated by 3 year intervals
21 years: 7 waves separated by 3 year intervals

Secondary Outcome Measures

Outcome Measure
Time Frame
LASA study: Mini Mental Status Examination
Time Frame: 21 years: 7 waves separated by 3 year intervals
21 years: 7 waves separated by 3 year intervals
LASA study: Verbal Fluency Test: Phonemic fluency
Time Frame: collected at 7th wave after 21 years (cross-sectional)
collected at 7th wave after 21 years (cross-sectional)
LASA study: Verbal Fluency Test: Semantic fluency
Time Frame: collected at 7th wave after 21 years (cross-sectional)
collected at 7th wave after 21 years (cross-sectional)
LASA study: Digit Span Forward from Wechsler Adult Intelligence Scale
Time Frame: collected at 7th wave after 21 years (cross-sectional)
collected at 7th wave after 21 years (cross-sectional)
LASA study: Digit Span Backward from Wechsler Adult Intelligence Scale
Time Frame: collected at 7th wave after 21 years (cross-sectional)
collected at 7th wave after 21 years (cross-sectional)
LASA study: 15-Words Test: Word Learning
Time Frame: 21 years: 7 waves separated by 3 year intervals
21 years: 7 waves separated by 3 year intervals
LASA study: 15-Words Test: Delayed Recall
Time Frame: 21 years: 7 waves separated by 3 year intervals
21 years: 7 waves separated by 3 year intervals
LASA study: Functional Independence Scale
Time Frame: 18 years: 6 waves with 3 year intervals
18 years: 6 waves with 3 year intervals
LASA study: Chair Stands Test
Time Frame: 21 years: 7 waves separated by 3 year intervals
21 years: 7 waves separated by 3 year intervals
LASA study: Walking Test
Time Frame: 21 years: 7 waves separated by 3 year intervals
21 years: 7 waves separated by 3 year intervals
LASA study: Cardigan Test
Time Frame: 21 years: 7 waves separated by 3 year intervals
21 years: 7 waves separated by 3 year intervals
LASA study: Balance Test
Time Frame: 21 years: 7 waves separated by 3 year intervals
21 years: 7 waves separated by 3 year intervals

Other Outcome Measures

Outcome Measure
Time Frame
InterRAI: Cognitive Performance Scale
Time Frame: 16 months
16 months
InterRAI: ADL Hierarchy Scale
Time Frame: 16 months
16 months
InterRAI: Timed 4 meter Walk Test
Time Frame: 16 months
16 months
InterRAI: Distance walked in past 3 days
Time Frame: 16 months
16 months
InterRAI: Hours of physical activity in past 3 days
Time Frame: 16 months
16 months
InterRAI: Days of coming outside in past 3 days
Time Frame: 16 months
16 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2016

Primary Completion (Actual)

June 1, 2016

Study Completion (Actual)

June 1, 2016

Study Registration Dates

First Submitted

October 18, 2016

First Submitted That Met QC Criteria

January 13, 2017

First Posted (Estimate)

January 19, 2017

Study Record Updates

Last Update Posted (Estimate)

January 19, 2017

Last Update Submitted That Met QC Criteria

January 13, 2017

Last Verified

January 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • DBI InterRAI LASA

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

Not Applicable: Permission to use the data should be obtained from the LASA and/or InterRAI researchers

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cognitive Function

3
Subscribe